Literature DB >> 16619275

Taste dysfunction in patients receiving radiotherapy.

Hideomi Yamashita1, Keiichi Nakagawa, Masao Tago, Naoki Nakamura, Kenshiro Shiraishi, Momoe Eda, Hiroki Nakata, Nami Nagamatsu, Rika Yokoyama, Mayuko Onimura, Kuni Ohtomo.   

Abstract

BACKGROUND: Taste loss is a major cause of morbidity in patients undergoing head and neck irradiation.
METHODS: In a prospective study, 51 patients undergoing radical head and neck irradiation at the Tokyo University Hospital were assessed for taste loss. Taste ability was measured by the taste threshold for the four basic tastes (sweet, sour, salt, and bitter qualities) plus another taste of "umami" quality using a filter-paper-disc method in patients before, during, and after radiotherapy (RT).
RESULTS: All tastes declined on the fifth week after the start of RT and improved on the 11th week. Anatomic pathologic analyses in rats revealed that taste buds diminished completely on the sixth day after irradiation of 15 Gy in a single fraction, and the appearance of taste buds returned almost to the preirradiation state on the 28th day.
CONCLUSIONS: The main cause of taste disorder resulting from RT was believed to be a disappearance of taste buds and not damage to the taste nerves.

Entities:  

Mesh:

Year:  2006        PMID: 16619275     DOI: 10.1002/hed.20347

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  23 in total

1.  The T cells in peripheral taste tissue of healthy human adults: predominant memory T cells and Th-1 cells.

Authors:  Pu Feng; Hong Wang; Roy S Feldman; Edmund A Pribitkin; Paul A S Breslin
Journal:  Chem Senses       Date:  2010-05-09       Impact factor: 3.160

Review 2.  Understanding the impact of taste changes in oncology care.

Authors:  Joel B Epstein; Gregory Smutzer; Richard L Doty
Journal:  Support Care Cancer       Date:  2016-01-28       Impact factor: 3.603

3.  Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.

Authors:  Javier Amézaga; Begoña Alfaro; Yolanda Ríos; Aitziber Larraioz; Gurutze Ugartemendia; Ander Urruticoechea; Itziar Tueros
Journal:  Support Care Cancer       Date:  2018-05-31       Impact factor: 3.603

4.  Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer.

Authors:  Jenny McGreevy; Ylva Orrevall; Kerstin Belqaid; Wendy Wismer; Carol Tishelman; Britt-Marie Bernhardson
Journal:  Support Care Cancer       Date:  2014-04-22       Impact factor: 3.603

5.  Taste disorders following cancer treatment: report of a case series.

Authors:  Joel B Epstein; Safira Marques de Andrade E Silva; Geena L Epstein; Jorge Henrique Santos Leal; Andrei Barasch; Gregory Smutzer
Journal:  Support Care Cancer       Date:  2019-03-29       Impact factor: 3.603

6.  Correlation of intensity-modulated radiation therapy at a specific radiation dose with the prognosis of nasal mucous damage after radiotherapy.

Authors:  Gendi Yin; Bo Tu; Ling Ye
Journal:  Radiat Environ Biophys       Date:  2020-02-06       Impact factor: 1.925

7.  Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T cells.

Authors:  Pu Feng; Karen K Yee; Nancy E Rawson; Lauren M Feldman; Roy S Feldman; Paul A S Breslin
Journal:  Brain Behav Immun       Date:  2009-03-04       Impact factor: 7.217

8.  Inflammation activates the interferon signaling pathways in taste bud cells.

Authors:  Hong Wang; Minliang Zhou; Joseph Brand; Liquan Huang
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

Review 9.  Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients.

Authors:  V Dilalla; G Chaput; T Williams; K Sultanem
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

10.  Changes in laryngeal sensation evaluated with a new method before and after radiotherapy.

Authors:  Kikuko Ozawa; Yasushi Fujimoto; Tsutomu Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.